Acceleron Pharma Reports Second Quarter 2015 Financial And Operational Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today provided a corporate update and reported financial results for the second quarter ended June 30, 2015.

Help employers find you! Check out all the jobs and post your resume.